Innate Pharma S.A. revenue breakdown overview

Innate Pharma S.A. revenue for the last year amounted to 66.95 M USD, the most of which — 66.64 M USD — came from its highest performing source at the moment, Research and Development of Pharmaceutical Products, the year earlier bringing 60.61 M USD. The greatest contribution to the revenue figure was made by France — last year it brought Innate Pharma S.A. 66.64 M USD, and the year before that — 60.61 M USD.